Publications in 2025
Serrano J, Martínez-Cuadrón D, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Herrera P, Simón JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo M, Benavente C, Lorenz JLL, Pérez-Encinas MM, Vidriales MB, Aparicio-Pérez C, de la Torre EP, Colorado M, de Rueda B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero MI, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Torres L, Boluda B, Sánchez-Garcia J, Montesinos P. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience. TRANSPLANTATION AND CELLULAR THERAPY. 2025. 299.e1-299.e14. DOI:10.1016/j.jtct.2025.02.011. IF: 4,4 Q1 D2
Rodríguez M, Rojas-Vega F, Díaz-Alejo JF, Mahillo-Fernández I, Serrano C, López A, Morales-Ruiz T, Roldan-Arjona T, Sánchez-García J, Río-Machín A, Morillo D, Pérez MA, Córdoba R, Llamas-Sillero P, Rodríguez-Pinilla SM, Serrano-López J. CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. FRONTIERS IN IMMUNOLOGY. 2025. -. DOI:10.3389/fimmu.2025.1693730. IF: 5,9 Q1 D2
De Heredia APLF, Ortiz MR, Llergo JT, Bailen MC, De Castro MS, de la Mata MF, Exposito AD, Cabeza AIP, Ortega MD, Fortesi MG, Valenzuela IF, Muñoz MC, Fernández AR, Almodóvar AMR, Cubiles IAD, Martínez FE, Huelva FJC, Fernandez JJS, Rubio DM, Andalusian Soc Cardiol. Clinical profile and cardiovascular events in patients with atrial fibrillation and hematologic malignancies with recent initiation of targeted therapy: Real-life data from CANAC-FA registry. CURRENT PROBLEMS IN CARDIOLOGY. 2025. -. DOI:10.1016/j.cpcardiol.2024.102974. IF: 3,3 Q2 D3
Munárriz D, Pérez-Lopez E, Rodríguez CM, Luque M, Esquirol A, Calvo CM, Aparicio C, Peña-Muñoz F, Fernando IH, Ormtegi IO, Marín AJS, Fernández-Luis S, Domínguez-García JJ, Fernández SV, Lopez-Lorenzo JL, Fleitas CA, González-Rodriguez AP, García L, Torrado T, Filaferro S, Balsalobre P, Cascon MJP, Rovira M, Salas MQ. Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC. FRONTIERS IN IMMUNOLOGY. 2025. -. DOI:10.3389/fimmu.2025.1700463. IF: 5,9 Q1 D2
Valhondo I, Pera A, Hassouneh F, López-Sejas N, Alvarez-Heredia P, Bergua JM, Arcos MJ, Casas-Avilés I, Sánchez-García J, Serrano J, Martín C, Durán E, Alonso C, Solana R, Tarazona R. Expression of the inhibitory checkpoints LAG-3, TIM-3, and PD-1 in NK cells and T cells in acute myeloid leukemia: preserved expression of LAG-3 is associated with patient survival. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2025. -. DOI:10.1007/s00262-025-04169-y. IF: 5,1 Q1 D3
Castón JJ, Aparicio C, Paez-Vega A, López LP, García E, Martín C, Ruiz-Arabi E, Cuesta-Casas MA, Bermúdez-Rodriguez MA, Cerezo-Martín JM, González-Sierra PA, Machuca I, Domínguez FMM, Saldaña-Moreno R, Herrera C, Torre-Cisneros J. Impact of CMV-specific immune reconstitution at the end of letermovir prophylaxis on the development of late cytomegalovirus infection in haematopoietic stem cell transplant recipients (INMUNOEND): a protocol for a prospective, observational, multicentre study. BMJ OPEN. 2025. -. DOI:10.1136/bmjopen-2025-101289. IF: 2,3 Q2 D3
Rodríguez-Arbolí E, Rodríguez-Veiga R, Soria-Saldise E, Bergua JM, Caballero-Velázquez T, Arnán M, Vives S, Serrano J, Bernal T, Martínez-Sánchez P, Tormo M, Rodríguez-Medina C, Herrera-Puente P, Lavilla-Rubira E, Boluda B, Acuña-Cruz E, Cano I, Cáceres S, Ballesteros J, Falantes J, Martínez-Cuadrón D, Pérez-Simón JA, Montesinos P. A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX. CANCER. 2025. -. DOI:10.1002/cncr.35618. IF: 5,1 Q1 D3
Jiménez-Vicente C, Esteve J, Baile-González M, Pérez-López E, Calvo CM, Aparicio C, Ormategi IO, Esquirol A, Peña-Muñoz F, Fernandez-Luis S, Fernando IH, González-Rodríguez AP, López-García A, López-Lorenzo JL, Torrado T, Marín AJS, Fleytas CA, García L, Villar S, Filaferro S, Balsalobre P, Cascón MJP, Salas MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). BLOOD CANCER JOURNAL. 2025. -. DOI:10.1038/s41408-025-01223-x. IF: 11,6 Q1 D1
Boluda B, Rodriguez-Veiga R, Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Soria-Saldise E, Bilbao C, de la Torre EP, Navarro I, Martínez-Cuadron D, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martínez-Sanchez P, Carrillo-Cruz E, Serrano J, Alonso-Domínguez JM, García R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, García-Pérez MJ, Morán J, Pérez-Santaolalla E, Alonso-Vence N, Oliva A, López JA, Barrios M, García-Fortes M, Olave MT, Labrador J, Martínez-López J, Calasanz MJ, García-Sanz R, Pérez-Simón JA, Gómez-Casares MT, Sánchez-Garcia J, Mendizabal Y, Barragán E, Montesinos P, PETHEMA Grp. Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study. CANCERS. 2025. -. DOI:10.3390/cancers17050854. IF: 4,4 Q2 D3
Pinto FR, Cascos E, Pérez-López E, Baile-González M, Rodríguez CM, Cascon MJP, Luque M, Esquirol A, Calvo CM, Peña-Muñóz F, Fernando IH, Ormtegi IO, Marin AJS, Fernandez-Luis S, Domínguez-García JJ, Fernández SV, Lorenzo JLL, Giron MFD, Pinedo LG, García L, Gonzalez-Rodriguez AP, Torrado T, Filaferro S, Basalobre P, López-García A, Ortí G, Chacón MJ, Salas MQ. Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC. FRONTIERS IN IMMUNOLOGY. 2025. -. DOI:10.3389/fimmu.2025.1571678. IF: 5,9 Q1 D2
Solana-Altabella A, Navarro-Vicente I, Rodriguez-Arboli E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Cornacchia CO, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodriguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andres JL, Martinez-Cuadrón D, Montesinos P. Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. CANCERS. 2025. -. DOI:10.3390/cancers17172844. IF: 4,4 Q2 D3
Alfonso-Pierola A, Martinez-Cuadrón D, Rodríguez-Veiga R, Gil C, Martínez-Sánchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, García-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, Pérez-Simon JA, Rodríguez-Medina C, Bass-Maturana MF, López-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, Pérez-Encinas M, Barrios-García M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Durán A, Valero-Nuñez M, Casado-Calderón S, Balerdi A, Torres V, Fernández R, Noriega V, Stevenazzi M, Labrador J, León-Maldonado P, de Rueda-Ciller B, Arce-Fernández O, Amigo ML, Raposo-Puglia JA, Solé M, Boluda B, Ayala R, Barragán E, Montesinos P. Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry. LEUKEMIA. 2025. 2686-2696. DOI:10.1038/s41375-025-02744-x. IF: 13,4 Q1 D1
Fernández AF, Fortes MG, Díaz MT, Marco MLJ, García RC, de la Fuente A, López JS, Pérez MAM, Chaparro MAS, Delgado RG. Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial. CANCERS. 2025. -. DOI:10.3390/cancers17162678. IF: 4,4 Q2 D3
Shyam S, Nishi SK, Ni JQ, Martínez-González MA, Corella D, Schröder H, Martínez JA, Alonso-Gómez AM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Sánchez VM, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Gaforio JJ, Ruiz-Canela M, Fernández-Carrión R, Goday A, Garcia-Rios A, Torres-Collado L, Cueto-Galán R, Zulet MA, Prohens L, Casas R, Castillo-Hermoso MA, Tojal-Sierra L, Gomez-Pérez AM, García-Arellano A, Sorli JV, Castañer O, Arenas-Larriva AP, Oncina-Cánovas A, Goñi L, Fitó M, Babio N, Salas-Salvadó J. Pasta Consumption and Cardiometabolic Risks in Older Adults with Overweight/Obesity: A Longitudinal Analysis. JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION. 2025. 566-578. DOI:10.1080/27697061.2025.2463454. IF: 2,6 Q3 D
Torrent-Rodríguez A, Cascos E, Garcés VN, Pérez-López E, Baile-González M, Rodríguez CM, Cascón MJP, Luque M, Esquirol A, Calvo CM, Peña-Muñoz F, Fernando IH, Ormtegi IO, Marín AJS, Fernández-Luis S, Domínguez-García JJ, Fernández SV, Lorenzo JLL, Girón MFD, Pinedo LG, García-Maño L, González-Rodriguez AP, Torrado T, Filaferro S, Basalobre P, Ortí G, Rovira M, Chacón MJ, Salas MQ. Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation. CANCERS. 2025. -. DOI:10.3390/cancers17193128. IF: 4,4 Q2 D3
Lloret-Madrid P, Boluda B, Martínez-López J, Bergua J, Arboli ER, Labrador J, Sossa C, Gil C, Algarra L, Lavilla-Rubira E, Serrano J, de Rueda B, Ibañez F, González BJG, Amigo ML, Belmonte DG, Rodríguez-Medina C, Gómez-Roncero MI, Colorado M, Lorenzo JLL, Tormo M, Fernández OA, Cano-Ferri I, Solana-Altabella A, Foncillas MA, Pierola AA, Vives S, Núñez MV, López-Vidal H, Pérez-Santaolalla E, Ramos LH, Boyero RG, González LL, Roldán A, Calderón SC, Infante JB, Olave T, García-Suárez J, de Laiglesia A, Rodríguez-Veiga R, Trigo F, Martínez-Cuadrón D, Montesinos P. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study. CANCER. 2025. -. DOI:10.1002/cncr.35696. IF: 5,1 Q1 D3
Lasa M, Gonzalez C, Notarfranchi L, Zherniakova A, Alignani D, Burgos L, Calasanz MJ, Rodriguez-Otero P, Perez JJ, Gomez C, de la Calle VG, de Arriba F, Palomera L, Rivas MAA, Clavero E, Ocio EM, Gonzalez-Rodriguez AP, Lakhwani S, Ibañez A, Oriol A, Sureda A, Rosinol L, Siewert C, Orfao A, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Cedena MT, Martinez-Lopez J, Puig N, Paiva B. Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment. BLOOD. 2025. 964-970. DOI:10.1182/blood.2025029234. IF: 23,1 Q1 D1
Publications in 2024
Gil-Cosano JJ, Ubago-Guisado E, Llorente-Cantarero FJ, Marmol-Perez A, Rodriguez-Solana A, Pascual-Gazquez JF, Mateos ME, Molina-Hurtado JR, Garcia-Fontana B, Narciso PH, Klentrou P, Gracia-Marco L. Movement Behaviors and Bone Biomarkers in Young Pediatric Cancer Survivors: A Cross-Sectional Analysis of the iBoneFIT Project. NUTRIENTS. 2024. DOI: 10.3390/nu16223914. IF: 4,8 Q1 D2
Núñez-Jurado D, Payán-Pernía S, Alvarez-Ríos A, Jiménez-Jambrina M, Pérez-De-Soto IC, Palma-Vallellano AJ, Zapata-Bautista R, Hernández-Castellet JC, Garrastazul-Sánchez MP, Arqueros-Martínez V, Urbano-Ramos MD, Abdelkader-Maanan M, García-Lozano JR, Delgado-Pecellín C. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation. AMERICAN JOURNAL OF PERINATOLOGY. 2024. e893-e900. DOI: 10.1055/s-0042-1759646. IF: 1,5 Q2 D5
Cordoba R, Sánchez-García J, Domingo-Domenech E, Jiménez JL, Pozo AM, Carpio C, Bendaña A, González AJ, de Villambrosia SG, Codina JG, Navarro B, Rodríguez G, Naves A, Baeza L, García-Sancho AM. 18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study. EXPERT REVIEW OF HEMATOLOGY. 2024. 95-100. DOI: 10.1080/17474086.2024.2313457. IF: 2,3 Q2 D5
Fernández-Avilés C, González-Manzanares R, Ojeda S, Molina J, Heredia C, Resua A, Hidalgo F, López-Aguilera J, Mesa D, Anguita M, Castillo JC, Pana M. Diastolic function assessment with left atrial strain in long-term survivors of childhood acute leukemia. REVISTA ESPANOLA DE CARDIOLOGIA. 2024. 60-68. DOI: 10.1016/j.rec.2023.05.001. IF: 7,2 Q1 D2
Suárez EU, Boluda B, Lavilla E, Tormo M, Botella C, Gil C, Vives S, Rodríguez C, Serrano J, Sayas MJ, Martínez-Sánchez P, Ramos F, Bernal T, Algarra L, Bergua-Burgues JM, Pérez-Simón JA, Herrera P, Barrios M, Noriega-Concepción V, Raposo-Puglia JA, Ayala R, Barragán E, Martínez-Cuadrón D, Amigo ML, López-Lorenzo JL, Lázaro-García A, Guimaraes JE, Colorado M, García-Boyero R, De Rueda-Ciller B, Foncillas-García M, Hong A, Labrador J, Alonso-Dominguez JM, Montesinos P. Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?. ANNALS OF HEMATOLOGY. 2024. 2845-2851. DOI: 10.1007/s00277-024-05840-7. IF: 3 Q2 D4
Labrador J, Martínez-Cuadrón D, Boluda B, Serrano J, Gil C, Pérez-Simón JA, Bernal T, Bergua JM, Martínez-López J, Rodríguez-Medina C, Vidriales MB, García-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-DomínguezJM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodríguez-Macías G, Mena-Durán A, Pérez-Encinas MM, Arce-Fernández O, Cuello R, Sánchez-García J, Gómez-Casares MT, Chillón MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragán E, Montesinos P. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry. CANCER. 2024. 3436-3451. DOI: 10.1002/cncr.35431. IF: 6,1 Q1 D2
Ribera JM, Morgades M, García-Calduch O, Sirvent M, Buendía B, Cervera M, Luzardo H, Hernández-Rivas JM, Sitges M, García-Cadenas I, Abrisqueta P, Montesinos P, Bastos-Oreiro M, de Llano MPQ, Bravo P, Torrent A, Herrera P, Garcia-Guiñon A, Vall-llovera F, Serrano J, Terol MJ, Bergua JM, García-Noblejas A, Barrenetxea C, Llorente L, García-Belmonte D, Gimeno E, Cladera A, Mercadal S, Sancho JM. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial. HAEMATOLOGICA. 2024. 543-552. DOI: 10.3324/haematol.2023.283342. IF: 8,2 Q1 D2
Ribera JM, Morgades M, García-Calduch O, Sirvent M, Buendía B, Cervera M, Luzardo H, Hernández-Rivas JM, Sitges M, García-Cadenas I, Abrisqueta P, Montesinos P, Bastos-Oreiro M, de Llano MPQ, Bravo P, Torrent A, Herrera P, Garcia-Guiñon A, Vall-llovera F, Serrano J, Terol MJ, Bergua JM, García-Noblejas A, Barrenetxea C, Llorente L, García-Belmonte D, Gimeno E, Cladera A, Mercadal S, Sancho JM. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial. REVISTA CHILENA DE LITERATURA. 2024. 543-552. DOI: 10.3324/haematol.2023.283342. IF: No consta Q D
Abrisqueta P, González-Barca E, Ferrà C, Ríos-Herranz E, de la Mata MF, Delgado J, Andreu R, Hernández-Rivas JA, Terol MJ, Navarro A, Vidriales MB, Baltasar P, De la Serna J, Ramirez A, Ballester C, Moreno C, García-Marco JA, Córdoba R, Yáñez L, Casado LF, González M, Bosch F. Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC). ECLINICALMEDICINE. 2024. DOI: 10.1016/j.eclinm.2024.102642. IF: 9,6 Q1 D1
Díez-Campelo M, López-Cadenas F, Xicoy B, Lumbreras E, González T, González MD, Sánchez-García J, Jordà RC, Slama B, Hernández-Rivas JA, Thepot S, Bernal T, Guerci-Bresler A, Bargay J, Amigo ML, Preudhomme C, Fenwarth L, Platzbecker U, Götze KS, Arar A, Toribio S, Del Cañizo C, Hernández-Rivas JM, Fenaux P. Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3trial. LANCET HAEMATOLOGY. 2024. e659-e670. DOI: 10.1016/S2352-3026(24)00142-X. IF: 15,4 Q1 D1
Cabrero M, López-Corral L, Jarque I, de la Cruz-vicente F, Pérez-López E, Valcárcel D, Sanz J, Espigado I, Ortí G, Martín-Calvo C, de la Serna J, Caballero D. Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial. BONE MARROW TRANSPLANTATION. 2024. 359-365. DOI: 10.1038/s41409-023-02171-5. IF: 4,5 Q1 D2
Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Serrano J, Herrera P, Simón JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo ML, Benavente C, Lorenzo JLL, Pérez-Encinas MM, Vidriales MB, Colorado M, de Rueda B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero MI, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry. HAEMATOLOGICA. 2024. 115-128. DOI: 10.3324/haematol.2022.282506. IF: 8,2 Q1 D2
Mingot-Castellano ME, García-Donas G, Campos-Alvarez RM, de Mora MCFS, Luis-Navarro J, Domínguez-Rodríguez JF, Nieto-Hernández MD, Sanchez-Bazán I, Yera-Cobo M, Cardesa-Cabrera R, Jiménez-Gonzalo FJ, Caparrós-Miranda I, Entrena-Urena L, Herrera SJ, Jiménez DF, Díaz-Canales D, Moreno-Carrasco G, Calderón-Cabrera C, Núñez-Vázquez RJ, Pedrote-Amador B, Bárcenas RJ. Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur Study. JOURNAL OF CLINICAL MEDICINE. 2024. DOI: 10.3390/jcm13216294. IF: 3 Q1 D2
Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatii P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy. MICROORGANISMS. 2024. DOI: 10.3390/microorganisms12040705. IF: 4,1 Q2 D4
Vives S, Quintela D, Morgades M, Cano-Ferri I, Serrano A, Acuña-Cruz E, Cervera M, Díaz-Beyá M, Vidriales B, Raposo-Puglia JA, Arnan M, Garrido A, Balerdi A, Cabello AI, Herrera-Puente P, Serrano J, Coll R, Tormo M, López-Marín J, García-Avila S, Casado MS, Padilla I, Rodríguez-Macías G, Calbacho M, Puchol A, Hernández A, Torres M, Costilla L, Colorado MM, Martínez-Cuadrón D, Esteve J, Montesinos P.. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. CANCERS. 2024. DOI: 10.3390/cancers16234028. IF: 4,5 Q1 D3
Puig N, Agullo C, Contreras T, Perez JJ, Aires I, Calasanz MJ, Garcia-Sanz R, Castro S, Martinez-Lopez J, Rodriguez-Otero P, Gonzalez-Calle V, Gonzalez MS, Oriol A, Gutierrez NC, Rios-Tamayo R, Rosinol L, Alvarez MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Inigo MB, de la Rubia J, Teruel AI, de Arriba F, Palomera L, Hernandez MT, Lopez-Jimenez J, Reinoso M, Garcia-Mateo A, Ocio EM, Blade J, Lahuerta JJ, Cedena MT, Paiva B, Miguel JFS, Mateos MV. Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome inpatients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. HAEMATOLOGICA. 2024. 4056-4066. DOI: 10.3324/haematol.2024.285742. IF: 8,2 Q1 D2
Jiménez-Bárcenas R, García-Donas-Gabaldón G, Campos-Alvarez RM, de Mora MCFS, Luis-Navarro J, Domínguez-Rodríguez JF, Nieto-Hernández MD, Sánchez-Bazán I, Yera-Cobo M, Cardesa-Cabrera R, Jiménez-Gonzalo FJ, Ruiz-Cobo MA, Caparrós-Miranda I, Entrena-Ureña L, Jiménez DF, Díaz-Canales D, Moreno-Carrasco G, Calderón-Cabrera C, Núñez-Vazquez RJ, Pedrote-Amador B, Mingot-Castellano ME. Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain-The Fostasur Study. BRITISH JOURNAL OF HAEMATOLOGY. 2024. 1977-1985. DOI: 10.1111/bjh.19443. IF: 5,1 Q1 D2
Publications in 2023
Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Rodriguez-Arboli E, Bilbao C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Casares MTG, Sanchez-Garcia J, Barragan E, Montesinos P. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. BLOOD CANCER JOURNAL. 2023. DOI: 10.1038/s41408-023-00835-5. IF: 12,8 Q1 D1
Aparicio-Perez C, de la Torre EP, Sanchez-Garcia J, Martin-Calvo C, Martinez-Losada C, Casano-Sanchez J, Serrano-Lopez J, Serrano J. Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?. CANCERS. 2023. DOI: 10.3390/cancers15051425. IF: 5,2 Q2 D3
Sanchez-Garcia J, Serrano J, de La Torre EP, Serrano-Lopez J, Aparicio-Perez C, Barragan E, Montesinos P. Identifying prognostic gene panels in acute myeloid leukemia. EXPERT REVIEW OF HEMATOLOGY. 2023. 277-287. DOI: 10.1080/17474086.2023.2193322. IF: 2,8 Q3 D
Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao-Sieyro C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Gomez-Casares MT, Sanchez-Garcia J, Barragan E, Montesinos P. Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. CANCERS. 2023. DOI: 10.3390/cancers15020438. IF: 5,2 Q2 D3
Heredia G, Gonzalez-Manzanares R, Ojeda S, Molina JR, Fernandez-Aviles C, Hidalgo F, Lopez-Aguilera J, Crespin M, Mesa D, Anguita M, Castillo JC, Pan MN. Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study. CANCERS. 2023. DOI: 10.3390/cancers15215158. IF: 5,2 Q2 D3
Lopez-Pedrera C, Oteros R, Ibáñez-Costa A, Luque-Tévar M, Muñoz-Barrera L, Barbarroja N, Chicano-Gálvez E, Marta-Enguita J, Orbe J, Velasco F, Perez-Sanchez C. The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2023. 2894-2907. DOI: 10.1016/j.jtha.2023.04.015. IF: 10,4 Q1 D1
de la Rubia J, Alonso R, Clavero ME, Askari E, Garcia A, Anton C, Fernandez M, Escalante F, Garcia A, Rios-Tamayo R, Conesa V, Bermudez MA, Merchan B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernandez PM, Alegre A. Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain. CANCERS. 2023. DOI: 10.3390/cancers15112964. IF: 5,2 Q2 D3
Montoro MJ, Pomares H, Coll R, del Castillo TB, Tormo M, Jimenez A, Brunet S, Casano J, Oiartzabal I, Diez-Campelo M, Ramos F, Romero R, Salido-Fierrez E, Pedro C, Bargay J, Munoz-Novas C, Lopez R, Rafel M, Valcarcel D. Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice. LEUKEMIA & LYMPHOMA. 2023. 679-690. DOI: 10.1080/10428194.2022.2154604. IF: 2,6 Q3 D
Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Martinez BG, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Pedroso RMA, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, de Heredia CD, Fuster JL. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet). FRONTIERS IN PEDIATRICS. 2023. DOI: 10.3389/fped.2023.1140637. IF: 2,6 Q2 D4
Chumbita M, Puerta-Alcalde P, Yáñez L, Cuesta MA, Chinea A, Español-Morales I, Fernandez-Abellán P, Gudiol C, González-Sierra P, Rojas R, Sánchez-Pina JM, Vadillo IS, Sánchez M, Varela R, Vázquez L, Guerreiro M, Monzo P, Lopera C, Aiello TF, Peyrony O, Soriano A, Garcia-Vidal C. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations. MICROBIOLOGY SPECTRUM. 2023. DOI: 10.1128/spectrum.00674-23. IF: 3,7 Q2 D5
García-Sancho AM, Rodríguez-Pinilla SM, Domingo-Domenech E, Climent F, Sánchez-Garcia J, Jiménez JL, Piqueras MGC, Castellvi J, González AJ, de Villambrosia SG, Codina JG, Navarro B, Rodríguez G, Borrero JJ, Fraga M, Naves A, Baeza L, Córdoba R. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. BRITISH JOURNAL OF HAEMATOLOGY. 2023. 182-193. DOI: 10.1111/bjh.18941. IF: 6,5 Q1 D3
Ramos F, Hermosín ML, Fuertes-Núñez M, Martínez P, Rodriguez-Medina C, Barrios M, Ibáñez F, Bernal T, Olave MT, Alvarez MA, Vahí M, Caballero-Velázquez T, González B, Altés A, García L, Fernández P, Durán MA, López R, Rafel M, Serrano J, Ranelletti FO. Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. JOURNAL OF PERSONALIZED MEDICINE. 2023. DOI: 10.3390/jpm13121667. IF: 3,4 Q2 D4
Publications in 2022
Berard E, Rollig C, Bertoli S, Pigneux A, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Dumas PY, Montesinos P, Recher C. BLOOD CANCER JOURNAL. 2022. DOI: 10.1038/s41408-022-00700-x
Hernandez-Boluda JC, Martinez-Cuadron D, Pereira A, Rodriguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martinez-Lopez J, Bergua J, Algarra L, Bernal T, Lopez-Lorenzo JL, Colorado M, Lopez A, Tormo M, Sayas MJ, Trigo F, Lopez-Pavia M, Perez-Simon JA, Lavilla-Rubira E, Rodriguez-Medina C, Rodriguez-Gutierrez JI, Sanz-Caballer MA, Montesinos P. LEUKEMIA RESEARCH. 2022. DOI: 10.1016/j.leukres.2022.106821
Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas MQ, Bastos-Oreiro M, Perez A, Hernani R, Viguria MC, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D. CANCERS. 2022. DOI: 10.3390/cancers14112673
Gonzalez-Manzanares R, Castillo JC, Molina JR, Ruiz-Ortiz M, Mesa D, Ojeda S, Anguita M, Pan M. CANCERS. 2022. DOI: 10.3390/cancers14061513
Labrador J, Martinez-Cuadron D, de la Fuente A, Rodriguez-Veiga R, Serrano J, Tormo M, Rodriguez-Arboli E, Ramos F, Bernal T, Lopez-Pavia M, Trigo F, Martinez-Sanchez MP, Rodriguez-Gutierrez JI, Rodriguez-Medina C, Gil C, Belmonte DG, Vives S, Foncillas MA, Perez-Encinas M, Novo A, Recio I, Rodriguez-Macias G, Bergua JM, Noriega V, Lavilla E, Roldan-Perez A, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14092342
Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14112817
Albasanz-Puig A, Dura-Miralles X, Laporte-Amargos J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, Garcia E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Marquez-Gomez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, del Pozo JL, Yanez L, Tilley R, Manzur A, Novo A, Pallares N, Bergas A, Carratala J, Gudiol C. MICROORGANISMS. 2022. DOI: 10.3390/microorganisms10040733
Gomez VG, Regano LD, Villa AR, Rubio CD, Vicent MG, Serra IB, Fernandez JM, Martinez AIP, Hurtado JMP, Duarte ML, Regalado MSM, Perez-Martinez A. ANALES DE PEDIATRIA. 2022. DOI: 10.1016/j.anpedi.2021.02.015
Lopez JS, Jimenez-Jimenez C, Chutipongtanate S, Serrano J, Rodriguez-Moreno M, Jimenez A, Jimenez Y, Pedrero SG, Lainez D, Alonso-Dominguez JM, Sillero PL, Piris MA, Sanchez-Garcia J. LEUKEMIA & LYMPHOMA. 2022. DOI: 10.1080/10428194.2022.2056173
Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Garcia-Sancho AM, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022. DOI: 10.1007/s12185-022-03367-z
Ayala R, Carreno-Tarragona G, Barragan E, Boluda B, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao C, Sanchez-Garcia J, Bernal T, Martinez-Cuadron D, Gil C, Serrano J, Rodriguez-Medina C, Bergua J, Perez-Simon JA, Calbacho M, Alonso-Dominguez JM, Labrador J, Tormo M, Amigo ML, Herrera-Puente P, Rapado I, Sargas C, Vazquez I, Calasanz MJ, Gomez-Casares T, Garcia-Sanz R, Sanz MA, Martinez-Lopez J, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14235799
Recher C, Rollig C, Berard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Pigneux A, Montesinos P. LEUKEMIA. 2022. DOI: 10.1038/s41375-021-01425-9
Macias-Sanchez MD, Morata-Tarifa C, Cuende N, Cardesa-Gil A, Cuesta-Casas MA, Pascual-Cascon MJ, Pascual A, Martin-Calvo C, Jurado M, Perez-Simon JA, Espigado I, Lopez SG, Sanchez GC, Mata-Alcazar-Caballero R, Sanchez-Pernaute R. STEM CELLS TRANSLATIONAL MEDICINE. 2022. DOI: 10.1093/stcltm/szac003
Castano-Bonilla T, Barragan E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, Garcia-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-Lopez J, Martinez-Lopez J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Bernal-Del Castillo T, Larrayoz MJ, Amigo R, Jimenez-Velasco A, Sanchez J, Ayala R, Blas C, Lainez D, Serrano-Lopez J, Sanz MA, Alonso-Dominguez JM, Montesinos P. DISEASE MARKERS. 2022. DOI: 10.1155/2022/3132941
Vilorio-Marques L, Fernandez CC, Mora E, Gutierrez L, Bua BR, Lorenzo MJJ, Beya MD, Pampliega MV, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Santa JAD, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T. THERAPEUTIC ADVANCES IN HEMATOLOGY. 2022. DOI: 10.1177/20406207221127547
Chumbita M, Puerta-Alcalde P, Yanez L, Cuesta MA, Chinea A, Morales IE, Abellan PF, Gudiol C, Guerreiro M, Gonzalez-Sierra P, Rojas R, Pina JMS, Vadillo IS, Varela R, Vazquez L, Lopera C, Monzo P, Garcia-Vidal C. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022. DOI: 10.1093/jac/dkac135
Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Simoes C, Herrera P, Calasanz MJ, Alfonso-Pierola A, Paiva B, Martinez-Lopez J, San Miguel JF, Prosper F, Montesinos P. FRONTIERS IN ONCOLOGY. 2022. DOI: 10.3389/fonc.2022.1054458
Martinez-Cuadron D, Megias-Vericat JE, Serrano J, Martinez-Sanchez P, Rodriguez-Arboli E, Gil C, Aguiar E, Bergua J, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodriguez-Medina C, Lopez-Pavia M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodriguez-Gutierrez JI, Benavente C, Costilla-Barriga L, Garcia-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, Garcia-Belmonte D, Herraez MM, Esteves GV, Gomez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P. BLOOD ADVANCES. 2022. DOI: 10.1182/bloodadvances.2021005335
Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives S, Sevilla J, Lopez AM, Romero MP, Montoya C, Vagace JM, Hurtado JRM, Garcia-Morin M, Abos MG, Sanchez MCM, Lendinez F, Moraleda PP, Tallon M, Gonzalez B, Urrutia E, Serna JV, Pleguezuelos IP, Merino MM, Elbal ER, Orellana E, Munoz HB, Berrueco R. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2022. DOI: 10.1111/jth.15699
Publications in 2021
Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 202 41(2):865-877. DOI: 10.1161/ATVBAHA.120.315346.
IF: 8,311 Q1 D1
Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P. A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. CANCER. 2021. 127(12):2003-2014. DOI: 10.1002/cncr.33403.
IF: 6,86 Q1 D2
Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021. 56(8):1919-1928. DOI: 10.1038/s41409-021-01264-
IF: 5,483 Q1 D3
Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. LEUKEMIA & LYMPHOMA. 2021. 62(12):2928-2938. DOI: 10.1080/10428192021.1948031.
IF: 3,28 Q3
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. BLOOD. 2021. 137(14):1879-1894. DOI: 10.1182/blood.2020007311.
IF: 22,113 Q1 D1
Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2021. 192(1):82-99. DOI: 10.1111/bjh.16741.
IF: 6,998 Q1 D2
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. BONE MARROW TRANSPLANTATION. 2021. 56(6):1281-1290. DOI: 10.1038/s41409-020-01157-x.
IF: 5,483 Q1 D3
Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients. ANNALS OF HEMATOLOGY. 2021. 100(8):1995-2004. DOI: 10.1007/s00277-020-04360-4.
IF: 3,673 Q2 D5
Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. JOURNAL OF MEDICAL ECONOMICS. 2021. 24(1):628-636. DOI: 10.1080/13696998.2021.191674
IF: 2,448 Q2 D5
Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2021. 106(6):842-850. DOI: 1111/ejh.13618. IF: 2,997 Q3
Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?. LEUKEMIA. 2021. 35(6):1571-1585. DOI: 10.1038/s41375-020-01058-4.
IF: 11,528 Q1 D1
Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. LEUKEMIA. 2021. 35(8):2358-2370. DOI: 10.1038/s41375-021-01126-3.
IF: 11,528 Q1 D1
Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA. Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics. ELIFE. 2021. 10():-. DOI: 10.7554/eLife.66190.
IF: 8,14 Q1 D1
Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P. Management of acquired hemophilia A: results from the Spanish registry. BLOOD ADVANCES. 2021. 5(19):3821-3829. DOI: 10.1182/bloodadvances.2021004626.
IF: 6,799 Q1 D2
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. FRONTIERS IN PEDIATRICS. 2021. 8():-. DOI: 10.3389/fped.2020.614521.
IF: 3,418 Q1 D2
Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial. BLOOD ADVANCES. 2021. 5(3):760-770. DOI: 10.1182/bloodadvances.2020003195. IF: 6,686 Q1 D2
Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. HAEMATOLOGICA. 2021. 106(12):3079-3089. DOI: 10.3324/haematol.2020.263806.
IF: 9,941 Q1 D2
Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. SCIENTIFIC REPORTS. 2021. 11(1):-. DOI: 10.1038/s41598-021-00050-x.
IF: 4,38 Q1 D3
Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. 21(12):E985-E999. DOI: 10.1016/j.clml.2021.07.022.
IF: 3,231 Q3
Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children. BONE MARROW TRANSPLANTATION. 2021. 56(5):1213-1216. DOI: 10.1038/s41409-020-01172-y. IF: 5,483 Q1 D3
Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. CANCERS. 20 13(10):-. DOI: 10.3390/cancers13102458.
IF: 6,639 Q1 D3
Publications in 2020
Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragan E, Arnan M, Serrano J, Tormo M, Bergua JM, Colorado M, Salamero O, Esteve J, Benavente C, Perez-Encinas M, Coll R, Marti-Tutusaus JM, Brunet S, Sierra J, Sanz MA, Montesinos P, Ribera JM, Vive. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols. EUROPEAN JOURNAL OF HAEMATOLOGY. 2020. 105 (2):138-147 DOI: 10.1111/ejh.13417
IF: 2,22 Q: 3
Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Banas H, Casas-Aviles I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R. Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia. CANCERS. 2020. 12 (8):- DOI: 10.3390/cancers12082171
IF: 6,126 Q: 1
Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-A. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2020. 192 (1):82-99 DOI: 10.1111/bjh.16741
IF: 5,518 Q: 1
Gudiol C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HP, Brunel AS, Garcia E, Isler B, Kern WV, M. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020. 64 (4):- DOI: 10.1128/AAC.02494-19
IF: 4,904 Q: 1
Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M. Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia. JOURNAL OF PERSONALIZED MEDICINE. 2020. 10 (4):- DOI: 10.3390/jpm10040244
IF: 4,433 Q: 1 D: 1
De Mier MVPR, Ojeda R, Alvarez-Lara MA, Navas A, Alonso C, Caballero-Villarraso J, Aljama P, Alvarez MA, Soriano S, Rodriguez M, Martin-Malo A. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients. BMC NEPHROLOGY. 2020. 21 (1):227- DOI: 10.1186/s12882-020-01885-8
IF: 1,913 Q: 3
Serrano-Lopez J, Fernández JL, Lumbreras E, Serrano J, Martinez-Losada C, Martin C, Hernandez-Rivas JM, Sanchez-Garcia J. Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD. BONE MARROW TRANSPLANTATION. 2020. 55 (8):1668-1670 DOI: 10.1038/s41409-020-0848-y
IF: 4,725 Q: 1
Rodriguez-Medina C, Martínez-Cuadron D, Cano I, Gil C, Tormo M, Martinez-Sanchez MD, del Castillo TB, Serrano-Lopez J, Benavente C, Herrera-Puente P, Garcia-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Llorisn MJ, Bergua-Burgues JM, Perez-Simon JA, Rodrigu. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study. LEUKEMIA RESEARCH. 2020. 92 ():- DOI: 10.1016/j.leukres.2020.106352
IF: 2,214 Q: 3
Mira E, Yarce OA, Ortega C, Fernandez S, Pascual NM, Gomez C, Alvarez MA, Molina IJ, Lama R, Santamaria M. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2020. 8 (8):2793-2795 DOI: 10.1016/j.jaip.2020.06.046
IF: 7,574 Q: 1
Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Ab. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. 20 (8):E513-e522 DOI: 10.1016/j.clml.2020.03.011
IF: 2,298 Q: 3
Publications in 2019
Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas J; A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. LEUKEMIA RESEARCH. 2019 Jan;76:1-10. doi: 10.1016/j.leukres.2018.11.006.
IF: 2,066 Q: 3
Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, K; An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. LEUKEMIA & LYMPHOMA. 2019 Apr;60(4):1030-1035. doi: 10.1080/10428194.2018.1516875.
IF: 2,674 Q: 3
Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morino D, Campo PH, G; Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2019 Mar 1;11(1):e2019016. doi: 10.4084/MJHID.2019.016.
IF: 1,586 Q: 4
Garcia-Cadenas I, Yanez L, Jarque I, Martino R, Perez-Simon JA, Valcarcel D, Sanz J, Bermudez A, Munoz C, Calderon-Cabrera C, Garcia E, Alonso L, Suarez-Lledo M, Gonzalez Vicent M, Heras I, Viguria MC, Batlle M, Vazquez L, Lopez J, Solano C; Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2019 Jun;102(6):465-471. doi: 10.1111/ejh.13226.
IF: 2,217 Q: 3
Alonso L, Gonzalez-Vicent M, Belendez C, Badell I, Sastre A, Rodriguez-Villa A, Bermudez-Cortes M, Hladun R, de Heredia CD; Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON). MEDICINA CLINICA. 2019 Feb 15;152(4):135-140. doi: 10.1016/j.medcli.2018.05.013.
IF: 1,277 Q: 3
Martos L, Fernandez-Pardo A, Lopez-Fernandez MF, Ibanez F, Herrero S, Tassies D, Gonzalez-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldan V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vaya A, Bonanad S, Ferrando F, Marti E, Cid A; Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency. THROMBOSIS AND HAEMOSTASIS. 2019 Sep;119(9):1409-1418. doi: 10.1055/s-0039-1692440.
IF: 4,733 Q: 1
Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, Garcia E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, de la Calle GM, Manzur A, Marin JI, Marquez-Gomez I, Martin-Davila P, Mikulska M, Mon; Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study. BMJ OPEN. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744.
IF: 2,413 Q: 2
Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E; Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. CANCER. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156.
IF: 6,102 Q: 1
Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML; Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. PLATELETS. 2019;30(6):743-751. doi: 10.1080/09537104.2018.1513476.
IF: 3,106 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germin; Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUKEMIA & LYMPHOMA. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893.
IF: 2,674 Q: 3
Rodriguez-Veiga R, Montesinos P, Garcia E, Boluda B, Rojas R, Serrano J, Martinez-Cuadron D, Martin C, Sanz J, Tabares S, Pinana JL, Lorenzo I, Montoro J, Salavert M, Peman J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA; Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients. MYCOSES. 2019 May;62(5):418-427. doi: 10.1111/myc.12891.
IF: 3,065 Q: 2
Bento L, Bastida JM, Garcia-Cadenas I, Garcia-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martinez-Munoz ME, Fernandez-Aviles F, Roldan E, Chinea A, Yanez L, Zudaire T, Vaz CP, Espigado I, Lopez J, Valcarcel D, Duarte R, Cabrera R, Herrera C, Gonza. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant; Real life outcomes of patients aged >= 75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. LEUKEMIA & LYMPHOMA. 2019 Nov;60(11):2720-2732. doi: 10.1080/10428194.2019.1607327.
IF: 2,674 Q: 3
Publications in 2018
Martinez-Losada C, Serrano-Lopez J, Serrano-Lopez J, Noguera NI, Garza E, Piredda L, Lavorgna S, Consalvo MAI, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jerez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibanez M, Sempere A, Sanz MA, Lo-Coco F, Sanchez-Garcia J. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes. HAEMATOLOGICA. 2018; 103(9):E400-E403.
IF: 9,09 Q: 1 D: 1
Sanchez-Garcia J, Falantes J, Perez AM, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Rodriguez MS, Casano FJ, Calderon C, Labrador M, Vahi M, Serrano J, Lumbreras E, Hernandez-Rivas JM. Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. LEUKEMIA & LYMPHOMA. 2018; 59(5):1095-1104.
IF: 2,644 Q: 2
Perez-Sanchez C, Arias-de la Rosa I, Aguirre MA, Luque-Tevar M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Abalos-Aguilera MC, Collantes-Estevez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martinez C, Gonzalez-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, Lopez-Pedrera C. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. HAEMATOLOGICA. 2018; 103(5):908-918.
IF: 9,09 Q: 1 D: 1
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM. Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2018; 24(8):1754-1758.
IF: 4,484 Q: 1
de la Fuente FDA, Duran MS, Alvarez MA, Sanroman IL, Dios AM, Tamayo RR, Garcia R, Gonzalez MS, Prieto E, Barez A, Escalante F, Tejedor A, Ballesteros M, Cabanas V, Capote FJ, Couto C, Garzon S, Gonzalez-Pardo M, Manteca MVM. Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation. SEMINARS IN HEMATOLOGY. 2018; 55(4):189-196.
IF: 3,926 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort. BLOOD ADVANCES. 2018; 2(8):923-932.
Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P. A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. ANNALS OF HEMATOLOGY. 2018; 97(5):763-772.
IF: 2,845 Q: 2
Serrano-Lopez J, Nattamai K, Pease NA, Shephard MS, Wellendorf AM, Sertorio M, Smith EA, Geiger H, Wells SI, Cancelas JA, Privette Vinnedge LM. 2.-Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors. EXPERIMENTAL HEMATOLOGY 2018 Mar;59:40-50
IF: 2.436 Q: 2
Zhang C, D'Alessandro A, Wellendorf AM, Mohmoud F, Serrano-Lopez J, Perentesis JP, Komurov K, Alexe G, Stegmaier K, Whitsett JA, Grimes HL, Cancelas JA. 3.- KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia. ONCOTARGET 2018 Jul 3;9(51):29665-29679.
IF: 3,45 Q: 2
Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM. Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUK LYMPHOMA. 2019. Jan;60(1):246-249
IF: 2.644 Q: 2
